| Literature DB >> 19344950 |
Arunabh Sekhri1, Delong Liu, Muhammad Rasul, Nasir Ahmed, Tauseef Ahmed, Karen Seiter.
Abstract
Allogeneic stem cell transplantation is considered to be a curative treatment modality in patients with chronic myelogenous leukemia. However patients are at risk for relapse years after transplantation. Currently we present two patients who relapsed 16 and 24 years after allogeneic bone marrow transplantation, respectively. These patients emphasize the need for long term follow-up of such patients.Entities:
Mesh：
Year: 2009 PMID： 19344950 DOI： 10.1016/j.leukres.2009.03.010
Source DB: PubMed Journal: Leuk Res ISSN： 0145-2126 Impact factor: 3.156